Journal article

Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes?

Kamlesh Khunti, Samuel Seidu, Melanie J Davies

Diabetes Obes Metab | Published : 2019